explore -WSS

explore

author：comprehensive 2025-09-28 02:28:28 - browse：887

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： When women are denied an abortion, their children fare worse than peers

WSS

Chimpanzees, like humans and whales, get menopause: Study

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Bill would stop addiction treatment from triggering child abuse inquiry

3 questions for the future of Biden's cancer moonshot

The future of health care in the House

Physician subsidies by hospitals soar in wake of No Surprises Act

focus

explore

hotspot

Jerome Adams on the need for new antivirals for Covid

FDA has safety concerns on CRISPR

Guidelines to prevent youth baseball injuries need more muscle

The pink breast cancer awareness ribbon needs a redesign

As demand for Covid shots wanes, Moderna seeks its next success

Hospitals warn Medicare's drug payment fix is ‘unlawful’

BioMarin wins approval for gene therapy to treat hemophilia A

Telehealth options flood the market as retailers push virtual care

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Liquid biopsy for lung cancer is launched by Delfi

focus

Why age limits for politicians are a terrible idea

VC firm General Catalyst wants to buy a health system

Chan Zuckerberg Biohub Chicago to focus on inflammation

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

explore

explore

leisure time

Wikipedia